BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 26091707)

  • 21. Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma.
    Wang X; Sun W; Bai J; Ma L; Yu Y; Geng J; Qi J; Shi Z; Fu S
    Mol Biol Rep; 2009 May; 36(5):861-9. PubMed ID: 18418730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression.
    Koo BH; Kim Y; Je Cho Y; Kim DS
    Eur J Pharmacol; 2015 Oct; 764():413-423. PubMed ID: 26187313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.
    Song K; Wang H; Krebs TL; Kim SJ; Danielpour D
    Cancer Res; 2008 Oct; 68(19):8173-82. PubMed ID: 18829577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1.
    Chen Y; Yu G; Yu D; Zhu M
    J Exp Clin Cancer Res; 2010 Aug; 29(1):104. PubMed ID: 20684793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of TGF-β on ocular surface epithelial cells.
    Benito MJ; Calder V; Corrales RM; García-Vázquez C; Narayanan S; Herreras JM; Stern ME; Calonge M; Enríquez-de-Salamanca A
    Exp Eye Res; 2013 Feb; 107():88-100. PubMed ID: 23220729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in levels of mRNAs of transforming growth factor (TGF)-beta1, -beta2, -beta3, TGF-beta type II receptor and sulfated glycoprotein-2 during apoptosis of mouse uterine epithelium.
    Wada K; Nomura S; Morii E; Kitamura Y; Nishizawa Y; Miyake A; Terada N
    J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):367-75. PubMed ID: 9010342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-beta1 and TGFBR1 are expressed in ameloblasts and promote MMP20 expression.
    Gao Y; Li D; Han T; Sun Y; Zhang J
    Anat Rec (Hoboken); 2009 Jun; 292(6):885-90. PubMed ID: 19462458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of transforming growth factor alpha gene expression in an ovarian surface epithelial cell line derived from a human carcinoma.
    Jindal SK; Ishii E; Letarte M; Vera S; Teerds KJ; Dorrington JH
    Biol Reprod; 1995 May; 52(5):1027-37. PubMed ID: 7626702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
    Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
    Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1.
    Gerdes MJ; Larsen M; Dang TD; Ressler SJ; Tuxhorn JA; Rowley DR
    Prostate; 2004 Feb; 58(3):299-307. PubMed ID: 14743470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
    Baldwin RL; Tran H; Karlan BY
    Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-β signaling participates in the maintenance of the primordial follicle pool in the mouse ovary.
    Wang ZP; Mu XY; Guo M; Wang YJ; Teng Z; Mao GP; Niu WB; Feng LZ; Zhao LH; Xia GL
    J Biol Chem; 2014 Mar; 289(12):8299-311. PubMed ID: 24515103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
    Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
    Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
    Kim IY; Zelner DJ; Lee C
    Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-glucose stimulation of L-arginine transport and nitric oxide synthesis results from activation of mitogen-activated protein kinases p42/44 and Smad2 requiring functional type II TGF-beta receptors in human umbilical vein endothelium.
    Vásquez R; Farías M; Vega JL; Martin RS; Vecchiola A; Casanello P; Sobrevia L
    J Cell Physiol; 2007 Sep; 212(3):626-32. PubMed ID: 17427197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydrotestosterone enhances transforming growth factor-beta-induced apoptosis in hormone-sensitive prostate cancer cells.
    Bruckheimer EM; Kyprianou N
    Endocrinology; 2001 Jun; 142(6):2419-26. PubMed ID: 11356690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of transforming growth factor β1 in malignant prostate cells is partly caused by a runaway of TGF-β1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-β type I receptor.
    Yu N; Kozlowski JM; Park II; Chen L; Zhang Q; Xu D; Doll JA; Crawford SE; Brendler CB; Lee C
    Urology; 2010 Dec; 76(6):1519.e8-13. PubMed ID: 21030067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars.
    Bran GM; Goessler UR; Schardt C; Hormann K; Riedel F; Sadick H
    Int J Mol Med; 2010 Jun; 25(6):915-21. PubMed ID: 20428796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZNF580 mediates eNOS expression and endothelial cell migration/proliferation via the TGF-β1/ALK5/Smad2 pathway.
    Luo Y; Zhao Y; Li X; Zhao J; Zhang W
    Mol Cell Biochem; 2014 Aug; 393(1-2):199-207. PubMed ID: 24771066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.